OIS XIII Speakers 2023
Maryam joined Regenxbio as Senior Director for Regulatory Strategy earlier this year building on her prior leadership experience at AbbVie as Medical Director of Clinical…
Read More
Dr. Nick Pliam joined Decheng Capital at its inception in 2011 and is based in its Menlo Park office. Trained as an orthopedic surgeon and…
Read More
Barbara Wirostko MD, a serial entrepreneur, is the CMO and Co-founder of Qlaris Bio as well as Co-founder and Medical Advisor to MyEyes. As a…
Read More
Dr. Heah is an accomplished executive who brings over two decades of drug development and commercial experience, focused primarily in gene therapy and ophthalmology. She…
Read More
Dr. Navratil has served as our chief development officer since April 2022. He previously served as our senior vice president, research and development since joining…
Read More
Abla Creasey is the Vice President of Therapeutics Development. In this capacity, she leads all programs in Translational and Clinical development, with a focus on…
Read More
Retinal specialist with both extensive basic science training, clinical trial experience and drug development experience in Big Pharma. Main research interest is macular diseases, including…
Read More
Dr. Sherif joined Oculis as CEO in 2017 from Novartis where he served as Entrepreneur in Residence at the Novartis Venture Fund and since 2022,…
Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.
![OIS-ANTERIOR-NEW-DATE-750x420[4300]](https://ois.net/wp-content/uploads/2020/03/OIS-ANTERIOR-NEW-DATE-750x4204300.jpg "OIS-ANTERIOR-NEW-DATE-750x420[4300]")